You are here

  • Home
  • Archive
  • Volume 21, Issue 3
  • Adjunctive use of intrapartum foetal ST-segment analysis (STAN) confers no benefit over conventional foetal heart rate monitoring

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Adjunctive use of intrapartum foetal ST-segment analysis (STAN) confers no benefit over conventional foetal heart rate monitoring

Authors

  • Alexandros Lazaridis Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare NHS Trust, Du Cane Road, London, UK PubMed articlesGoogle scholar articles
  • Christoph C Lees Department of Surgery and Cancer, Imperial College London, London, UK Queen Charlotte's and Chelsea Hospitals, Imperial College Healthcare NHS Trust, London and Department of Development and Regeneration, KU Leuven, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to : Dr Christoph C Lees , Department of Surgery and Cancer, Imperial College London SW7; Queen Charlotte's and Chelsea Hospitals, Imperial College Healthcare NHS Trust, London and Department of Development and Regeneration, KU Leuven, Belgium; christoph.lees{at}imperial.nhs.uk
View Full Text

Citation

Lazaridis A, Lees CC
Adjunctive use of intrapartum foetal ST-segment analysis (STAN) confers no benefit over conventional foetal heart rate monitoring
BMJ Evidence-Based Medicine 2016;21:105-106.

Publication history

  • First published March 16, 2016.
Online issue publication 
May 19, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/